A retrospective study was conducted to identify the relationship between Alzheimer disease or other neurocognitive disorders and previous treatment with chemotherapy for colorectal cancer.
Although many Americans are at risk of developing colorectal cancer, they may not be aware of their own specific risk factors that they could have for it. What should medical professionals be teaching their patients about on regarding the risks, symptoms, detection, and prevention of colorectal cancer?
A team of researchers conducted a meta-analysis to determine the variation in incidence of venous thromboembolism following resection for colorectal cancer.
Researchers aimed to describe the impact of the COVID-19 pandemic on the diagnosis of Barrett esophagus and esophagogastric cancer in Northern Ireland.
A team of investigators conducted a prospective cohort study to assess the impact of population-based FIT screening on CRC-related mortality and advanced-stage disease.
A team of investigators sought to determine the relationship between circulating sex hormones and risk of esophageal, gastric, and colorectal cancers in both men and women.
A team of investigators explored the ability of different machine learning models to predict the risk of gastric cancer development in patients who had undergone eradication of Helicobacter pylori infection.
Patients with colorectal cancer (CRC) were prospectively enrolled into 2 cohorts and asked to wear a fitness tracker for 4 days at baseline and at follow-up.
A team of investigators sought to assess the prevalence of Barrett esophagus in a large cohort of women with systemic sclerosis or scleroderma who underwent esophagogastroduodenoscopy.
The American Cancer Society’s annual report approximates the new cancer diagnoses and deaths expected in 2021 and identifies impactful patterns in oncology care.
A team of investigators conducted a systematic review and meta-analysis to provide to assess the risk for colorectal cancer in patients with inflammatory bowel disease.
This prospective cross-sectional study determined the specificity of Cologuard®, a multitarget stool DNA test, in an average-risk screening population of 45- to 49 year-olds.
The researchers’ goal was to determine which dimensions of smoking increase the risk for gastric intestinal metaplasia, which is a precursor lesion of gastric cancer.
Investigators assessed disparities in patient access to therapies approved for the treatment of gastrointestinal malignancies in the United States, the United Kingdom, Europe, and Ireland, as well as benefit relative to cost.
Investigators compared the cost-effectiveness of selective internal radiotherapy (SIRT) of that of sorafenib in the locally advanced hepatocellular carcinoma setting.
